Repligen (RGEN) PT Lowered to $150 at Deutsche Bank
Get Alerts RGEN Hot Sheet
Price: $180.29 +2.23%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 11
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 11
Join SI Premium – FREE
Deutsche Bank analyst Justin Bowers lowered the price target on Repligen (NASDAQ: RGEN) to $150.00 (from $165.00) while maintaining a Hold rating.
You May Also Be Interested In
- JPMorgan Downgrades Limbach Holdings (LMB) to Underweight
- Medibank Pvt Ltd. (MPL:AU) (MDBPF) PT Lowered to AUD5 at Citi
- Universal Store Holdings (UNI:AU) PT Raised to AUD12.96 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share